A Malignant Masquerade: Ileocecal Tuberculosis Presenting as an Ulceroproliferative Colonic Mass in a Young Woman Authors: Sowmya Gatram, Viswanathan Pandurangan, Devasena Srinivasan Published: 2026 ABSTRACT Ileocaecal tuberculosis is the most common form of intestinal tuberculosis and can occasionally mimic colonic malignancy, resulting in diagnostic challenges. We report a case of a 32-year-old woman presenting with generalized fatigue, significant weight loss, and bilateral pedal edema. Laboratory investigations revealed severe macrocytic anemia with elevated inflammatory markers. Stool occult blood negative. Colonoscopy revealed an ulceroproliferative friable growth causing luminal narrowing. Whole-body positron emission tomography-computed tomography (PET-CT) demonstrated non-segmental circumferential thickening involving the terminal ileum, ileocaecal junction, cecum, ascending colon, and proximal transverse colon with surrounding fat stranding and adjacent lymphadenopathy. Histopathological examination showed granulomatous colitis with positivity for acid-fast bacilli (AFB). AFB Gene expert was sent, turned out to be positive, confirming intestinal tuberculosis. The patient was treated with weight-based anti-tubercular therapy and showed significant clinical improvement, with considerable weight gain and normalization of hemoglobin levels. This case highlights the importance of considering intestinal tuberculosis in the differential diagnosis of colonic masses, though its proliferative, particularly in tuberculosis-endemic regions like India. Introduction Tuberculosis (TB) remains a major infectious disease burden worldwide, and India continues to account for a substantial proportion of global TB cases [1]. Although pulmonary disease is the most frequent manifestation, extrapulmonary TB continues to pose diagnostic challenges because it may affect almost any organ system and often presents with nonspecific constitutional symptoms [2]. Abdominal TB can involve the gastrointestinal tract, peritoneum, mesenteric lymph nodes, and solid abdominal organs, either singly or in combination [2,3]. The ileocecal region is the most frequently involved intestinal site. Its susceptibility has been attributed to abundant lymphoid tissue, relative physiological stasis, increased absorptive activity, and prolonged contact between luminal contents and the mucosa [2,3]. Intestinal TB may appear as ulcerative, hypertrophic, ulcerohypertrophic, or stricturing disease; the hypertrophic and ulcerohypertrophic forms can produce mass-like lesions and luminal narrowing [2,4]. The clinical importance of this entity lies in its ability to mimic Crohn disease (CD) and colorectal malignancy. Constitutional symptoms, anemia, bowel wall thickening, regional lymphadenopathy, and ulceroproliferative lesions on colonoscopy may direct clinicians toward malignancy, while granulomatous inflammation may raise the possibility of Crohn disease [5,6]. This overlap is particularly relevant in endemic regions, where failure to consider intestinal TB can lead to delayed treatment or unnecessary surgical intervention. We present a young woman with severe malnutrition and macrocytic anemia whose ulceroproliferative ileocolonic lesion initially suggested malignancy but was ultimately confirmed as rifampicin-sensitive intestinal TB. Case presentation A 32-year-old woman with no known comorbidities presented with generalized fatigue for one year and bilateral lower-limb swelling for one week. She also reported anorexia, intermittent low-grade fever for three months, and significant unintentional weight loss from 48 kg to 28 kg over two years. There was no history of contact with a patient with TB, prior TB treatment, family history of malignancy, bleeding per rectum, menorrhagia, or altered bowel or bladder habits. On examination, she was severely undernourished with a body mass index of 12.6 kg/m2. Pallor, raised jugular venous pressure, and bilateral pitting pedal edema were present. There was no icterus, cyanosis, clubbing, or peripheral lymphadenopathy. Her blood pressure was 100/60 mmHg, and her pulse rate was 112 beats/minute. Cardiovascular examination revealed normal heart sounds without murmurs. Respiratory examination showed equal breath sounds bilaterally with minimal infrascapular crepitations. Abdominal examination revealed no organomegaly or palpable mass, and neurological examination showed no focal deficit. The initial clinical concern was occult gastrointestinal disease, including malignancy, because of chronic constitutional symptoms, severe weight loss, and profound anemia. The laboratory parameters are shown in Table 1. Table 1Baseline laboratory parameters with reference ranges.ParameterPatient valueReference rangeUnitsHemoglobin (Hb)3.8Female: 12-15g/dLMean corpuscular volume (MCV)11483-101fLMean corpuscular hemoglobin (MCH)4027-33pgPlatelet count3.621.5-4.5lakh/cmmBlood urea nitrogen (BUN)67-18mg/dLSerum creatinine0.60.6-1.3mg/dLLactate dehydrogenase (LDH)283<80U/LSerum iron1460-180µg/dLTotal iron-binding capacity (TIBC)439168-585µg/dLSerum ferritin150.713-150ng/mLVitamin B12170200-900pg/mLErythrocyte sedimentation rate (ESR)67Female: 4-19mm/hrC-reactive protein (CRP)9.5<0.6mg/dL Baseline laboratory parameters with reference ranges. The key investigations are summarized in Table 2. Table 2Key clinical investigations and findings.ELISA: enzyme-linked immunosorbent assay; HCV: hepatitis C virus; MTB/RIF: mycobacterium/rifampicin; PET-CT: positron emission tomography-computed tomography.InvestigationsFindingsPeripheral smearLow RBC count with macrocytic RBCs and few macro-ovalocytes; normal leukocyte count; adequate platelets; no hemoparasitesStool occult bloodNegative on two consecutive samplesViral markersHIV, HBsAg, and HCV non-reactive (ELISA)Chest radiographNo cavitation or active pulmonary lesionUltrasound abdomenGallbladder polyp; otherwise unremarkableUpper gastrointestinal endoscopy and biopsyFeline esophagus, Hill grade II hiatus hernia, antral erythema; biopsy showed H. pylori-associated chronic gastritis with reflux changes and no granuloma, dysplasia, or malignancyInitial limited colonoscopy5-mm pedunculated sigmoid polyp removed in toto; histopathology showed tubular adenoma with focal high-grade dysplasia and focal cryptitisWhole-body PET-CTNon-segmental circumferential thickening involving the terminal ileum, ileocecal junction, cecum, ascending colon, and proximal transverse colon with surrounding fat stranding and adjacent lymphadenopathyRepeat colonoscopyUlceroproliferative friable growth causing mild luminal narrowing in the cecum, distal ascending colon, and transverse colonBiopsy from ulceroproliferative lesionGranulomatous colitis with acid-fast bacilli positivity (Ziehl-Neelsen staining)Xpert MTB/RIF assayPositive for Mycobacterium tuberculosis; rifampicin resistance not detected Key clinical investigations and findings. ELISA: enzyme-linked immunosorbent assay; HCV: hepatitis C virus; MTB/RIF: mycobacterium/rifampicin; PET-CT: positron emission tomography-computed tomography. Because of severe symptomatic anemia, two units of packed red blood cells were transfused, after which hemoglobin increased to 7.4 g/dL. Given the macrocytosis and low vitamin B12 level, parenteral vitamin B12 supplementation was initiated with 2000 mcg intravenously daily for seven days, followed by weekly dosing for six weeks. The first colonoscopy was limited to the sigmoid colon because the patient could not tolerate further negotiation despite bowel preparation. The finding of a sigmoid tubular adenoma with focal high-grade dysplasia, together with constitutional symptoms and PET-CT findings, strengthened the initial suspicion of malignancy (Figure 1). PET-CT with avid FDG uptake in the ileocecal region. (a) CT image of the abdomen showing (1) mass lesion in the cecum, (2) pericolic lymphadenopathy; (b) PET image showing increased FDG uptake in cecum and associated lymph nodes; (c) fused PET-CT image confirming metabolically active disease in the cecum and regional lymph nodes; (d) CT image of the abdomen showing (3) mass lesion in the terminal ileum; (e) PET image showing increased FDG uptake in terminal ileum; (f) fused PET-CT image confirming metabolically active disease in terminal ileum. PET-CT: positron emission tomography-computed tomography, FDG: fluorodeoxyglucose. A repeat colonoscopy after adequate preparation demonstrated an ulceroproliferative friable lesion causing mild luminal narrowing in the cecum, distal ascending colon, and transverse colon (Figures 2, 3). Chest radiograph showing no evidence of active pulmonary tuberculosis. Ultrasound abdomen showing cholelithiasis as demonstrated above. No skip lesions or crypt abscesses were identified in the remaining visualized bowel. Although these endoscopic findings were concerning for malignancy, biopsy from the ulceroproliferative lesion showed granulomatous colitis with acid-fast bacilli (AFB) positivity (Figure 4). The Xpert MTB/RIF assay was positive for M. tuberculosis and did not detect rifampicin resistance (Figures 5, 6). Colonoscopy showing an ulceroproliferative friable lesion in the right colon. Colonoscopy demonstrating mild luminal narrowing caused by the ulceroproliferative lesion. Histopathology of biopsy from the ulceroproliferative lesion showing granulomatous colitis. Acid-fast bacilli positivity supported the diagnosis of intestinal tuberculosis. A diagnosis of rifampicin-sensitive intestinal TB with predominant ileocecal and right colonic involvement was made. Weight-based anti-tubercular therapy (ATT) was started, and the patient was discharged with close follow-up. At subsequent follow-up, she tolerated ATT well and showed marked clinical improvement, including resolution of fever, weight gain of 12 kg, and normalization of hemoglobin to 13 g/dL. Discussion Intestinal tuberculosis represents one of the most common forms of extrapulmonary tuberculosis and remains a significant clinical problem in developing countries. Abdominal tuberculosis may involve several intra-abdominal sites, including the gastrointestinal tract, peritoneum, mesenteric lymph nodes, and solid organs such as the liver, spleen, and pancreas. Within the bowel, the ileocecal area is most frequently affected, with less common involvement of the jejunum and colon. Peritoneal disease commonly presents with ascites [7]. Abdominal tuberculosis may develop through multiple routes. These include swallowing infected respiratory secretions in patients with active pulmonary tuberculosis, hematogenous dissemination from a distant focus, lymphatic spread from involved lymph nodes, direct contiguous extension from nearby infected structures, and (less commonly) gastrointestinal inoculation after ingestion of unpasteurized dairy contaminated with Mycobacterium bovis region is the most frequently involved site, accounting for nearly 75% of gastrointestinal tuberculosis cases [8]. Several anatomical and physiological factors predispose this region to infection, including the abundance of lymphoid tissue, increased absorptive capacity, relative stasis, and the prolonged contact time between luminal contents and the intestinal mucosa. The clinical manifestations of intestinal tuberculosis are often nonspecific and may include abdominal pain, weight loss, fever, altered bowel habits, and anemia. These symptoms frequently overlap with those of other gastrointestinal conditions, such as inflammatory bowel disease and colorectal malignancy. As a result, diagnosis can be delayed, particularly when the disease presents with atypical morphological features. Morphologically, intestinal tuberculosis may present in three forms: ulcerative, hypertrophic, and ulceroproliferative. The ulcerative form is the most common, accounting for approximately 53% of cases, whereas the ulceroproliferative variant accounts for nearly 27%. The ulceroproliferative form can present as a mass-like lesion with circumferential bowel wall thickening, luminal narrowing, and regional lymphadenopathy, features that can closely resemble colorectal carcinoma on radiological imaging. In the present case, PET-CT demonstrated circumferential thickening involving the terminal ileum, ileocaecal junction, cecum, ascending colon, and proximal transverse colon with surrounding fat stranding and adjacent lymphadenopathy. Such findings are commonly associated with malignancy and may lead clinicians toward an initial diagnosis of colorectal cancer. However, similar radiological features may also be observed in intestinal tuberculosis due to inflammatory bowel wall thickening and granulomatous lymphadenitis. On CT scans, both cecal malignancy and ileocecal TB can present as asymmetric wall thickening of the terminal ileum or cecum associated with necrotic lymphadenopathy [9]. Endoscopic findings in intestinal tuberculosis are variable and may include ulcerations, nodules, strictures, or proliferative masses. Colonoscopy in this case revealed an ulceroproliferative friable growth causing mild luminal narrowing. Such lesions can closely mimic malignant tumors both macroscopically and endoscopically. Therefore, histopathological examination remains the cornerstone for definitive diagnosis. The presence of granulomatous inflammation on histology is suggestive of intestinal tuberculosis. However, it is not entirely specific, as granulomas may also be observed in Crohn's disease and certain fungal infections. CD typically presents with a longer duration of symptoms. In contrast, ileocecal tuberculosis (ITB) tends to have a shorter, more acute onset. The demonstration of acid-fast bacilli on special staining significantly strengthens the diagnosis [10]. In this patient, histopathological examination revealed granulomatous colitis with acid-fast bacilli positivity, confirming the diagnosis of intestinal tuberculosis. Another diagnostic challenge in this case was the presence of severe macrocytic anemia. While anemia is common in chronic infections, macrocytosis may reflect associated nutritional deficiencies, such as vitamin B12 or folate deficiency, which are frequently observed in patients with chronic malnutrition or malabsorption. The patient also had profound weight loss and severe undernutrition, further contributing to hematological abnormalities. Management of intestinal tuberculosis primarily involves medical therapy with standard anti-tubercular treatment regimens. Most patients respond well to pharmacological therapy, achieving significant clinical improvement and symptom resolution. Clinical analyses emphasize that while often indolent, ITB can lead to life-threatening emergencies like intestinal perforation, a rare but serious complication with mortality rates reaching 25% to 100% [11]. Surgical intervention is generally reserved for complications, such as obstruction, perforation, abscess formation, or diagnostic uncertainty. In this case, initiation of weight-based anti-tubercular therapy resulted in marked clinical improvement, with resolution of fever, substantial weight gain, and normalization of hemoglobin levels during follow-up. This favorable response further supports the diagnosis of intestinal tuberculosis. When testing is inconclusive, but suspicion is high, a therapeutic trial of anti-tuberculous therapy (ATT) is often initiated. A rapid clinical response, specifically significant weight gain (often >10% within three months), is a strong indicator of a correct diagnosis [12,13]. This case highlights the importance of maintaining a high index of suspicion for intestinal tuberculosis when evaluating colonic masses, particularly in tuberculosis-endemic regions. Failure to recognize this condition may result in misdiagnosis and unnecessary surgical interventions. Early endoscopic evaluation and biopsy are crucial for establishing the correct diagnosis and initiating appropriate therapy. Conclusions Ileocecal tuberculosis can present as an ulcero-proliferative colonic mass with luminal narrowing and systemic symptoms, closely mimicking colorectal malignancy. In tuberculosis-endemic regions, intestinal TB should be actively considered in the differential diagnosis of any right-sided colonic growth, even when imaging suggests cancer. Definitive diagnosis relies on colonoscopic biopsy with histopathology and mycobacterial testing (AFB staining and nucleic acid amplification test (NAATs), where available). Early initiation of appropriate anti-tubercular therapy leads to excellent clinical recovery and helps avoid unnecessary surgical intervention.